These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36933212)

  • 21. Postoperative radiotherapy in stage II or IIIA completely resected non-small cell lung cancer: a systematic review and practice guideline.
    Okawara G; Ung YC; Markman BR; Mackay JA; Evans WK;
    Lung Cancer; 2004 Apr; 44(1):1-11. PubMed ID: 15013578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative radiotherapy for resected pathological stage IIIA-N2 non-small cell lung cancer: a retrospective study of 221 cases from a single institution.
    Dai H; Hui Z; Ji W; Liang J; Lu J; Ou G; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; He J; Wang L
    Oncologist; 2011; 16(5):641-50. PubMed ID: 21482587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is surgery indicated for stage IIIA-N2 non-small-cell lung cancer?].
    Gounant V; Lavolé A; Epaud C; Rosencher L; Milleron B
    Rev Pneumol Clin; 2007 Jun; 63(3):135-7. PubMed ID: 17675936
    [No Abstract]   [Full Text] [Related]  

  • 24. Thoracic irradiation for patients with resected non-small cell lung cancer: adjuvant or salvage?
    Wagner H
    Cancer J; 2006; 12(4):253-6. PubMed ID: 16925969
    [No Abstract]   [Full Text] [Related]  

  • 25. Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
    Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
    Radiology; 2000 Jun; 215 Suppl():1295-318. PubMed ID: 11037548
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Postoperative radiotherapy for non-small cell lung cancer: Efficacy, target volume, dose].
    Dupic G; Bellière-Calandry A
    Cancer Radiother; 2016 Apr; 20(2):151-9. PubMed ID: 26996789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postoperative Radiotherapy for Resected Stage IIIA-N2 Non-small-cell Lung Cancer: A Population-Based Time-Trend Study.
    Zeng WQ; Feng W; Xie L; Zhang CC; Yu W; Cai XW; Fu XL
    Lung; 2019 Dec; 197(6):741-751. PubMed ID: 31705271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative radiotherapy in resected non-small-cell lung cancer: every creek has two banks.
    Johnson DH; Turrisi A
    Curr Oncol Rep; 2000 Jan; 2(1):51-3. PubMed ID: 11122824
    [No Abstract]   [Full Text] [Related]  

  • 30. [Postoperative radiotherapy in non-small cell lung cancer stage IIIA - N2: Focus and perspectives].
    Wang P; Duchemann B; Chouahnia K; Matton L; Benabadji A; Zelek L; Popotte H; Paix A
    Bull Cancer; 2023 Jan; 110(1):101-112. PubMed ID: 36241461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer.
    Movsas B
    Oncology (Williston Park); 2001 Dec; 15(12):1549-58. PubMed ID: 11780699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer.
    Feigenberg SJ; Hanlon AL; Langer C; Goldberg M; Nicolaou N; Millenson M; Coia LR; Lanciano R; Movsas B
    J Thorac Oncol; 2007 Apr; 2(4):287-92. PubMed ID: 17409799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice].
    Kepka L; Bujko K
    Pneumonol Alergol Pol; 2007; 75(3):256-61. PubMed ID: 17966101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients.
    Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G
    Radiother Oncol; 2010 Jul; 96(1):84-8. PubMed ID: 20541823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.
    Van Meerbeeck JP; Van Schil PE; Senan S;
    J Thorac Oncol; 2007 Dec; 2(12):1138-9. PubMed ID: 18090593
    [No Abstract]   [Full Text] [Related]  

  • 36. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
    Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
    Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.
    Vansteenkiste J; Betticher D; Eberhardt W; De Leyn P
    J Thorac Oncol; 2007 Aug; 2(8):684-5. PubMed ID: 17762333
    [No Abstract]   [Full Text] [Related]  

  • 39. Is postoperative radiotherapy for radically resected NSCLC detrimental and therefore unnecessary?
    Debevec M
    Lung Cancer; 2004 Dec; 46(3):379-80; discussion 381. PubMed ID: 15541825
    [No Abstract]   [Full Text] [Related]  

  • 40. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
    Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
    BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.